logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Sectors
ABVC
ABVC BioPharma, Inc.
0.86
2 x 0.62
2 x 1.09
bid
ask
+
0.03
3.31%
2 @ 07:30 PM
0.91 +0.05 (6.36%)
Ytd-59.74%
1y-69.70%
0.83
day range
0.90
0.71
52 week range
3.40
Open0.84Prev Close0.83Low0.83High0.90Mkt Cap22.86M
Vol113.48KAvg Vol138.14KEPS-0.30P/EN/AForward P/E-1.16
Beta0.82Short Ratio0.70Inst. Own3.01%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg1.20200-d Avg1.561yr Est2.02

ABVC News

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 38.0% to $3.45 during Monday's after-market se

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Aardvark Therapeutics (NASDAQ:AARD) shares increased by 8.5% to $6.28 during Friday's a

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market

benzinga.com
ABVC BioPharma Postpones Biokey (Cayman) Share Distribution, Rescheduled For August 21, 2026

 On August 3, 2026, ABVC BioPharma, Inc. (the "Company") determined to postpone the previous

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-mar

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
ABVC BioPharma Q1 EPS $(0.06), Same YoY

ABVC BioPharma (NASDAQ:ABVC) reported quarterly losses of $(0.06) per share. This is unchanged from

Contrasting ABVC BioPharma (NASDAQ:ABVC) and Edgewise Therapeutics (NASDAQ:EWTX)
defenseworld.net
Contrasting ABVC BioPharma (NASDAQ:ABVC) and Edgewise Therapeutics (NASDAQ:EWTX)

ABVC BioPharma (NASDAQ: ABVC - Get Free Report) and Edgewise Therapeutics (NASDAQ: EWTX - Get Free R

ABVC BioPharma (NASDAQ:ABVC) Stock Price Down 3.4% – Time to Sell?
defenseworld.net
ABVC BioPharma (NASDAQ:ABVC) Stock Price Down 3.4% – Time to Sell?

ABVC BioPharma, Inc. (NASDAQ: ABVC - Get Free Report)'s stock price was down 3.4% during trading on

Why Silo Pharma Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Silo Pharma Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket

SILO stock rose 51.8% in pre-market trading after its PTSD treatment pipeline received a patent from

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

ABVC BioPharma (NASDAQ:ABVC) Trading Up 11.3% – Here’s Why
defenseworld.net
ABVC BioPharma (NASDAQ:ABVC) Trading Up 11.3% – Here’s Why

ABVC BioPharma, Inc. (NASDAQ: ABVC - Get Free Report) shares were up 11.3% on Wednesday. The stock t

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

ABVC BioPharma (NASDAQ:ABVC) Trading Down 4.9% – Here’s What Happened
defenseworld.net
ABVC BioPharma (NASDAQ:ABVC) Trading Down 4.9% – Here’s What Happened

ABVC BioPharma, Inc. (NASDAQ: ABVC - Get Free Report)'s stock price was down 4.9% during mid-day tra
benzinga.com
ABVC BioPharma Q3 EPS $(0.05) Down From $(0.03) YoY, Sales $795.950K Up From $389.276K YoY

ABVC BioPharma (NASDAQ:ABVC) reported quarterly losses of $(0.05) per share. This is a 66.67 percent
benzinga.com
ABVC BioPharma Q2 EPS $(0.13) Down From $(0.09) YoY

ABVC BioPharma (NASDAQ:ABVC) reported quarterly losses of $(0.13) per share. This is a 44.44 percent
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session

ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners
globenewswire.com
ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Tota

FREMONT, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-s
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners
globenewswire.com
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 F

FREMONT, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-s

ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements
globenewswire.com
ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements

• Executed Global Licensing Agreements that could provide up to $292 million in income • Received Ca
benzinga.com
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
globenewswire.com
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per S

FREMONT, CA, April 18, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ: ABV

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
globenewswire.com
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expectin

FREMONT, CA, April 17, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: AB

ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
globenewswire.com
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Li

FREMONT, CA, April 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire --  ABVC BioPharma, Inc.  (NASDAQ:

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
globenewswire.com
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and

FREMONT, CA, March 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABV

ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
globenewswire.com
ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine

FREMONT, CA, March 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire --  ABVC BioPharma, Inc.  (NASDAQ:

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
globenewswire.com
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business U

FREMONT, CA, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: AB

ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
globenewswire.com
ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on

FREMONT, CA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABV

ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
globenewswire.com
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive D

FREMONT, CA , Feb. 12, 2024 (GLOBE NEWSWIRE) -- The Company holds a U.S. patent for the same treatme

ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
globenewswire.com
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share

FREMONT, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednes

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keef

ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees
globenewswire.com
ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment

FREMONT, CA , Jan. 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire   –  ABVC BioPharma, Inc.  (NASDAQ:

ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical Study
globenewswire.com
ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clin

FREMONT, CA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –  ABVC BioPharma, Inc . (NASDAQ: AB
benzinga.com
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's

Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the co

ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market
globenewswire.com
ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market

FREMONT, CA, Nov. 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABV

ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M
globenewswire.com
ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $20

FREMONT, CA, Nov. 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –  ABVC BioPharma, Inc.  (NASDAQ: AB
benzinga.com
Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday

Gainers

benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
Stocks That Hit 52-Week Lows On Friday

  Friday's session saw 169 companies set new 52-week lows.
benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 179 companies reached new 52-week lows.
benzinga.com
Stocks That Hit 52-Week Lows On Monday

  During Monday's session, 201 stocks hit new 52-week lows.
benzinga.com
Stocks That Hit 52-Week Lows On Friday

  During the Friday's sesion, 157 stocks hit new 52-week lows.
benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 155 companies set new 52-week lows.